Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06224218 · ClinicalTrials.gov registry record · NA
Prostate Single Port & Laser Enucleation Comparison Trial
A NA study of Prostate Hyperplasia, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 116
- Enrollment target
- 1
- Study location
NCT06224218: Recruiting NA study of Prostate Hyperplasia, sponsored by University of Illinois at Chicago.
NCT06224218 is a NA study of Prostate Hyperplasia that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 116 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06224218, a NA study of Prostate Hyperplasia, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
- 1
- Study location
Study Summary
Surgical treatments for benign prostatic hyperplasia (BPH) are necessary when non-procedural approaches fail to alleviate lower urinary tract symptoms (LUTS) or bladder outlet obstruction (BOO). Open simple prostatectomy and laser enucleation are recommended for prostatic adenoma size greater than 80 ml. Minimally invasive approaches, such as robotic-assisted simple prostatectomy, have gained popularity due to their comparable outcomes with lower morbidity. The introduction of the da Vinci single-port (SP) robotic platform offers potential advantages, but its outcomes have not been thoroughly investigated. This randomized controlled trial aims to compare the outcomes of SP simple prostatectomy performed using the da Vinci robotic platform versus thulium laser enucleation of the prostate for the treatment of BPH and BOO.
Primary Outcome
Time in minutes from the start to finish of the procedure.
Conditions Studied
Interventions
- PROCEDURE Single Port Robotic Surgery
- PROCEDURE Laser Surgery
Study Locations (1)
Illinois
- UI Health SCB Clinic Department of Urology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2024-01-15 |
| Est. Completion | 2027-08-15 |
| Phase | NA |
What NCT06224218 shows while recruiting
NCT06224218 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Prostate Hyperplasia appearing as the primary indexed condition, and to 2 interventions - of which Single Port Robotic Surgery is the first listed.
NCT06224218 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06224218 about?
NCT06224218 is a clinical study titled "Prostate Single Port & Laser Enucleation Comparison Trial". Surgical treatments for benign prostatic hyperplasia (BPH) are necessary when non-procedural approaches fail to alleviate lower urinary tract symptoms (LUTS) or bladder outlet obstruction (BOO). Open simple prostatectomy and laser enucleation are recommended for prostatic adenoma size greater than 8...
What is the current status of trial NCT06224218?
This trial is currently recruiting. It is a NA study. The enrollment target is 116 participants. The study started on 2024-01-15. Estimated completion is 2027-08-15.
What conditions does trial NCT06224218 study?
This clinical trial studies the following conditions: Prostate Hyperplasia.
What interventions are being tested in trial NCT06224218?
The interventions under investigation include: Single Port Robotic Surgery (PROCEDURE), Laser Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT06224218?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06224218 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Hyperplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06224218's enrollment target sits among peer trials
116 808th of 2000 higher than 1,191 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI